Scalable and accurate deep learning with electronic health records A Rajkomar, E Oren, K Chen, AM Dai, N Hajaj, M Hardt, PJ Liu, X Liu, ... NPJ digital medicine 1 (1), 1-10, 2018 | 2084 | 2018 |
1,135 genomes reveal the global pattern of polymorphism in Arabidopsis thaliana C Alonso-Blanco, J Andrade, C Becker, F Bemm, J Bergelson, ... Cell 166 (2), 481-491, 2016 | 1145 | 2016 |
Advances in risk classification and treatment strategies for neuroblastoma NR Pinto, MA Applebaum, SL Volchenboum, KK Matthay, WB London, ... Journal of clinical oncology 33 (27), 3008, 2015 | 819 | 2015 |
Epigenomic diversity in a global collection of Arabidopsis thaliana accessions T Kawakatsu, SSC Huang, F Jupe, E Sasaki, RJ Schmitz, MA Urich, ... Cell 166 (2), 492-505, 2016 | 627 | 2016 |
Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube MA Eckert, S Pan, KM Hernandez, RM Loth, J Andrade, SL Volchenboum, ... Cancer discovery 6 (12), 1342-1351, 2016 | 199 | 2016 |
Pharmacogenomics‐based point‐of‐care clinical decision support significantly alters drug prescribing PH O'Donnell, N Wadhwa, K Danahey, BA Borden, SM Lee, JP Hall, ... Clinical Pharmacology & Therapeutics 102 (5), 859-869, 2017 | 87 | 2017 |
A phase I new approaches to neuroblastoma therapy study of buthionine sulfoximine and melphalan with autologous stem cells for recurrent/refractory high‐risk neuroblastoma JG Villablanca, SL Volchenboum, H Cho, MH Kang, SL Cohn, ... Pediatric blood & cancer 63 (8), 1349-1356, 2016 | 87 | 2016 |
Neuroblastoma survivors are at increased risk for second malignancies: a report from the International Neuroblastoma Risk Group Project MA Applebaum, Z Vaksman, SM Lee, EA Hungate, TO Henderson, ... European Journal of Cancer 72, 177-185, 2017 | 84 | 2017 |
Gene expression profiling of E wing sarcoma tumours reveals the prognostic importance of tumour–stromal interactions: a report from the C hildren's O ncology G roup SL Volchenboum, J Andrade, L Huang, DA Barkauskas, M Krailo, ... The Journal of Pathology: Clinical Research 1 (2), 83-94, 2015 | 84 | 2015 |
Characterization of molecular defects in isovaleryl-CoA dehydrogenase in patients with isovaleric acidemia AWA Mohsen, BD Anderson, SL Volchenboum, KP Battaile, K Tiffany, ... Biochemistry 37 (28), 10325-10335, 1998 | 82 | 1998 |
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database DA Morgenstern, WB London, D Stephens, SL Volchenboum, T Simon, ... European Journal of Cancer 65, 1-10, 2016 | 76 | 2016 |
Second malignancies in patients with neuroblastoma: The effects of risk‐based therapy MA Applebaum, TO Henderson, SM Lee, N Pinto, SL Volchenboum, ... Pediatric blood & cancer 62 (1), 128-133, 2015 | 72 | 2015 |
Bioinformatic analysis and post-translational modification crosstalk prediction of lysine acetylation Z Lu, Z Cheng, Y Zhao, SL Volchenboum PloS one 6 (12), e28228, 2011 | 70 | 2011 |
Use of wearable, mobile, and sensor technology in cancer clinical trials SM Cox, A Lane, SL Volchenboum JCO clinical cancer informatics 2, 1-11, 2018 | 67 | 2018 |
Age, diagnostic category, tumor grade, and mitosis-karyorrhexis index are independently prognostic in neuroblastoma: an INRG project E Sokol, AV Desai, MA Applebaum, D Valteau-Couanet, JR Park, ... Journal of Clinical Oncology 38 (17), 1906, 2020 | 62 | 2020 |
Comprehensive Pediatric Hospital Medicine LB Zaoutis, VW Chang | 62 | 2007 |
CAPriCORN: Chicago area patient-centered outcomes research network AN Kho, DM Hynes, S Goel, AE Solomonides, R Price, B Hota, SA Sims, ... Journal of the American Medical Informatics Association 21 (4), 607-611, 2014 | 60 | 2014 |
Synergistic myeloma cell death via novel intracellular activation of caspase-10–dependent apoptosis by carfilzomib and selinexor S Rosebeck, MM Alonge, M Kandarpa, A Mayampurath, SL Volchenboum, ... Molecular cancer therapeutics 15 (1), 60-71, 2016 | 50 | 2016 |
Tailoring therapy for children with neuroblastoma on the basis of risk group classification: past, present, and future WH Liang, SM Federico, WB London, A Naranjo, MS Irwin, ... JCO Clinical Cancer Informatics 4, 895-905, 2020 | 49 | 2020 |
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group … DA Morgenstern, WB London, D Stephens, SL Volchenboum, B Hero, ... Journal of clinical oncology 32 (12), 1228, 2014 | 47 | 2014 |